Concepedia

Author

Gerhard Heil

Medizinische Hochschule Hannover

Also Known As

D. Kämpfe, G Heil, G. Heil, G. P. Heil, Gerhard Heil, M. Freund

196

Publications

10.8K

Citations

48

H-Index

49

Concepts

All Affiliations

Medizinische Hochschule HannoverGoethe University FrankfurtKlinikum LüdenscheidUniversität UlmUniversity Hospital Ulm
GH

About

Gerhard Heil is an author at Medizinische Hochschule Hannover specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

36

2.9K

2

Health Sciences

13

14

1.9K

3

Cell Biology

5

5

127

4

Allergy

1

1

63

5

Epidemiology

1

1

19

Gerhard Heil

×

88

Publications

10K

Citations

45

H-Index

YearCitations

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter,

New England Journal of Medicine

2008

1.6K

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Mathias Rummel, N. Niederle, Georg Maschmeyer,

The Lancet

2013

1.5K

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

D. Hoelzer, E. Thiel, H. Löffler,

Blood

1988

588

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Helmut Oettle, Hanno Riess, Jens Stieler,

Journal of Clinical Oncology

2014

476

Incidence and Prognostic Influence of <i>DNMT3A</i> Mutations in Acute Myeloid Leukemia

Felicitas Thol, Frédérik Damm, Andrea Lüdeking,

Journal of Clinical Oncology

2011

375

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz,

Blood

1997

331

Improved outcome in adult B-cell acute lymphoblastic leukemia

D. Hoelzer, WD Ludwig, E. Thiel,

Blood

1996

316

Impact of <i>IDH1</i> R132 Mutations and an <i>IDH1</i> Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Katharina Wagner, Frédérik Damm, Gudrun Göhring,

Journal of Clinical Oncology

2010

240

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Michael Lübbert, Björn Rüter, Rainer Claus,

Haematologica

2011

230

Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.

Wolfgang Ludwig, Harald Rieder, Claus R. Bartram,

PubMed

1998

190

Page 1